Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity
Franklin Covey Company (FC)
Last franklin covey company earnings: 4/2 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.franklincovey.com
Company Research
Source: Business Wire
Founded by a team of experts in aging biology, machine learning and drug development and based on pioneering research for resetting cell health by Dr. Janine Sengstack of UCSFJunevity’s RESET platform uses large-scale human data and AI to identify novel transcription factor targets and repress them with siRNAInitial focus is Type 2 diabetes, obesity and frailty, with the potential to address numerous indications SAN FRANCISCO--(BUSINESS WIRE)--Junevity, a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related diseases, today announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213130880/en/Left to right, Junevity co-founders CEO Dr. John Hoekman, Ph.D., chief scientific officer Dr. Janine Sengstack, Ph.D. and chief operating officer Rob Cahill. Junevity, a biotechnology company on a miss
Show less
Read more
Impact Snapshot
Event Time:
FC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FC alerts
High impacting Franklin Covey Company news events
Weekly update
A roundup of the hottest topics
FC
News
- Franklin Covey (NYSE:FC) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $22.00 price target on the stock.MarketBeat
- Franklin Covey Co. Enters into a $20 Million 10b5-1 Trading Plan to Repurchase Common Stock Under Existing $50 Million Authorization [Yahoo! Finance]Yahoo! Finance
- Franklin Covey Co. Enters into a $20 Million 10b5-1 Trading Plan to Repurchase Common Stock Under Existing $50 Million AuthorizationBusiness Wire
- Franklin Covey (NYSE:FC) had its price target lowered by analysts at Barrington Research from $27.00 to $22.00. They now have an "outperform" rating on the stock.MarketBeat
- Franklin Covey Reports Financial Results for Fourth Quarter and Full Fiscal 2025Business Wire
FC
Earnings
- 11/5/25 - Miss
FC
Sec Filings
- 12/19/25 - Form ARS
- 12/18/25 - Form DEF
- 11/25/25 - Form 4/A
- FC's page on the SEC website